The safety of oral hypoglycemic agents in the first trimester of pregnancy: A meta-analysis

Canadian Journal of Clinical Pharmacology

Volumn 10, Issue 4, 2003, Pages 179-183

  Gutzin, Sheryl J ^a   Kozer, Eran ^b   Magee, Laura A ^c   Feig, Denice S ^a   Koren, Gideon ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Oral hypoglycemic agents; Pregnancy

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DIABETES CONTROL; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MATERNAL DIABETES MELLITUS; META ANALYSIS; NEWBORN; NEWBORN MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0842300434     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Schardein JL. Chemically Induced Birth Defects, 2nd edn. New York: Marcel Dekker Inc, 1993.
2. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 5th edn. Baltimore: Williams & Wilkins, 1998.
3. Shepard TH. Catalog of Teratogenic Agents, 9th edn. Baltimore: The John Hopkins Univeristy Press, 1998.
4. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-hased case-control study. Pediatrics 1990;85:1-9.
5. Simpson JL, Elias S, Martin AO, Palmer MS, Ogata ES, Radvany RA. Diabetes in pregnancy, Northwestern University series (1977-1981). Am J Obstet Gynecol 1983;146:263-8.
6. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331-4.
7. Mills JL, Knopp RH, Simpson JL, et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988;318:671-6.
8. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin A1c and risk of major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989;39:225-31.
9. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes: Glycemic control prevents congenital anomalies. JAMA 1991;265:731-6.
10. Rosenn B, Miodovnik M, Combs A, Khoury J, Siddiqi TA. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84:515-20.
11. Engelau MH, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995;18:1029-33.
12. Velazquez EM, Mendoza S, Hamer T, Sosa F, Gluek CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647-54.
13. Harris RP, Helfand M, Woolf SH, et al, for the Methods Work Group, Third U.S. Preventative Services Task Force. Current Methods of the U.S. Preventative Services Task Force. A Review of the Process. Am J Prev Med 2001;20:21-35.
14. Jackson WP, Campbell GD, Notelovitz M, Blumsohn D. Tolbutamide and chlorpropamide during pregnancy in human diabetics. Diabetes 1962;11(Suppl):98-101.
15. Malins JM, Cooke AM, Pyke DA, Fitzgerald MG. Sulfonylurea drugs in pregnancy. Br Med J 1964;2:187.
16. Dolger H, Bookman JJ, Nechemias C. Tolbutamide in pregnancy and diabetes. J Mt Sinai Hosp 1969;36:471-4.
17. Notelovitz M. Sulfonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J 1971;45:226-9.
18. Sutherland HW, Bewsher PD, Cormack JD, et al. Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child 1974;49:283-91.
19. Soler NG, Walsh CH, Malins JM. Congenital malformations in infants of diabetic mothers. QJM 1976;45:303-13.
20. Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984;65:635-7.
21. Piacquadio K, Hollingsworth DR, Murphy H. Effects of in-utero exposure to oral hypoglycemic drugs. Lancet 1991;338:866-9.
22. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by N1DDM. Diabetes Care 1995;18:1446-51.
23. Botta RM. Congenital malformations in infants of 517 pregestational diabetic mothers. Ann 1st Super Sanita 1997;33:307-11.
24. Sutherland HW, Stower JM, Cormack JD, Bewsher PD. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br Med J 1973;3:9-13.
25. Douglas CP, Richards R. Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes 1967;16:60-91.
26. Temesio P, Belitzky R, Gallego L, Martell M, Pose SV. Congenital malformations in diabetic offspring. Acta Diabet Lat 1977;14:192-8.
27. Moss JM, Conner EJ. Pregnancy complicated by diabetes. Report of 102 pregnancies including eleven treated with oral hypoglycemic drugs. Med Ann DC 1965;34:253-60.
28. Dolger H, Bookman JJ, Nechemias, C. The diagnostic and therapeutic value of tolbutamide in pregnant diabetics. Diabetes 1962;11(Suppl):97-8.
29. Day RE, Insley J. Maternal diabetes mellitus and congenital malformation. Arch Dis Child 1976;51:935-8.
30. Coetzee EJ, Jackson WP. Metformin in management of pregnant insulin-dependent diabetics. Diabetologia 1979;16:241-5.
31. Coetzee EJ, Jackson WP. Diabetes newly diagnosed during pregnancy: A 4-year study at Groote Schuur Hospital. S Afr Med J 1979;56:467-75.
32. Coetzee EJ, Jackson WP. Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half-year study at Groote Schuur Hospital. S Afr Med J 1980;58:795-802.
33. Coetzee EJ, Jackson WP. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1986;1:281-7.
34. Hellmuth E, Damm P, Molsted-Pedersen, L. Congenital malformations in offspring of diabetic women treated with oral hypoglycaemic agents during embryogenesis. Diabet Med 1994;11:471-4.
35. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.
36. Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 1995;123:873-7.
37. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-34.